CJ-15,208

General Information


DRACP ID  DRACP00751

Peptide Name   CJ-15,208

Sequence  FpFW

Sequence Length  4

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
PC-3 Prostate carcinoma Carcinoma IC50=10.1±0.9 µM WST-1 assay  48h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antitumor; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Not available

N-terminal Modification  Lactam

C-terminal Modification  Not available

Other Modification  p=D-Proline

Chiral  Mix



Physicochemical Information


Formula  C29H28N4O3

Absent amino acids  ACDEGHIKLMNPQRSTVY

Common amino acids  F

Mass  53425

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  3

Net charge  0

Boman Index  829

Hydrophobicity  117.5

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  5500

Absorbance 280nm  1833.33

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28692379

Title  Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth

Doi 10.1080/15384047.2017.1345384

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.